Literature DB >> 30107625

Perioperative Management of Endocrine Active Adrenal Tumors.

Florentine Schreiner1, Gurpreet Anand1, Felix Beuschlein1,2.   

Abstract

Endocrine active adrenal tumors are associated with a relevant risk of complications during surgery, either due to direct hemodynamic effects of the hormone excess or due to hormone related comorbidities. Over the last decades, careful preoperative evaluation and improved peri-interventional medical management of affected patients has resulted in a significant reduction of perioperative complications. In addition, improvement in anesthesia and surgical techniques with the feasibility of laparoscopic adrenalectomy have contributed to reduce morbidity. Nevertheless, there are still several challenges to be considered in the perioperative care of these patients. Due to the rarity of functionally active adrenal tumors, there are no prospective data available to guide clinical management. Accordingly, most recommendations are based on retrospective data analysis, expert opinion or carry weak evidence based on small series or case reports. The aim of this review is to summarize the current knowledge and to suggest practical approaches to reduce perioperative complications in endocrine active adrenal tumors. This review exclusively deals with data from adult patients with functionally active adrenal tumors. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30107625     DOI: 10.1055/a-0654-5251

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  2 in total

1.  Hormonally Active Adrenal tumors; Challenges and Outcomes for Different Surgical Approaches.

Authors:  Husnu Aydin; Ahmet Cem Dural; Nuri Alper Sahbaz; Sezer Bulut; Deniz Guzey; Cevher Akarsu; Evin Bozkur; Mehmet Karabulut
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

2.  An unusual case of Adrenocortical Adenocarcinoma with Biochemical Masquerade of Pheochromocytoma.

Authors:  Muzaffar Ali; Lubna Mirza
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.